2920-86-7C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)OAPGDTXUMTIZLCJ-CGVGKPPMSA-NPrednisolone succinate is a hemisuccinate resulting from the formal condensation of the 21-hydroxy group prednisolone with one of the carboxy groups of succinic acid. It is used to treat mild to moderate non-infectious eye allergies and inflammation, including damage caused by chemical and thermal burns. It has a role as an anti-inflammatory drug. It is a hemisuccinate, a tertiary alpha-hydroxy ketone, a 17alpha-hydroxy steroid, an 11beta-hydroxy steroid, a 20-oxo steroid and a 3-oxo-Delta(1),Delta(4)-steroid. It is functionally related to a succinic acid and a prednisolone. It is a conjugate acid of a prednisolone succinate(1-).
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
This chemical does not meet GHS hazard criteria for 3.4% (1 of 29) of reports.
Danger
H360 (86.2%): May damage fertility or the unborn child [Danger Reproductive toxicity]
P203, P260, P280, P318, P319, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 29 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system.
用途副腎皮質ホルモン剤です。糖 質コルチコイドに二重結合を導入し、糖質コ ルチコイド作用を強めています。鉱質コルチ コイド作用を弱めた性質を有しています。
用途薬理研究用。
使用neuroleptic
現在のフィルター条件では反応記録がありません。
読み込み中…
2920-86-7DTXSID1048964CHEMBL485659CHEBI:135745